APR 21, 2020 8:05 AM PDT

Scientists develop tumor immunity map

A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecules. The map provides hope for expanding the number of patients who could be receptive to immunotherapy treatments. In developing the map, the research team behind the study analyzed human leukocyte antigens (HLAs) that are not typically included in HLA-based immunotherapies.

HLAs are important because HLA-restricted T cell responses can induce antitumor effects in cancer patients; however, previous studies have typically focused on the few HLA alleles prevalent in a specific subset of ethnic groups. These researchers wanted to expand the knowledge to include a wider population.

"Most studies have focused on HLA proteins that are commonly found in the general population," explains co-first author Kenji Murata, a postdoctoral fellow at the Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. "We have developed a new technique that allows the sampling of underrepresented HLA proteins to find peptides or antigens that can induce an anti-tumor immune response. We can then stimulate the patient's own immune cells with those peptides and give them back to the patient to help treat their cancer."

In their analysis, the team isolated T cells from patients with melanoma with 25 different types of HLAs. This combination let them analyze T cell interactions with more than 800 different antigen peptides. As the authors write in their study, “We were able to determine the specificity, on average, of 12.2% of the tumor-infiltrating T lymphocytes recognizing a mean of 3.1 shared antigen-derived epitopes across HLA-A, B, and C. Furthermore, we isolated a number of cognate T cell receptor genes with tumor reactivity.”

The researchers hope their map will broaden the audience of those cancer patients who are receptive to immunotherapies. "By querying human melanoma-derived T cells and using novel HLA proteins bearing common tumor antigens, we have been able to discover both new and existing immunologically active antigens in tumors," concludes senior author Naoto Hirano, Senior Scientist at the Princess Margaret Cancer Centre. "Our strategy allows for a more complete examination of the immune response and development of novel cancer vaccines and immunotherapies for a broader group of patients not limited by HLA prevalence or tumor mutation burden."

Sources: eLife, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 16, 2021
Cancer
Can you guess which drug is both antiviral and immunotherapeutic?
MAY 16, 2021
Can you guess which drug is both antiviral and immunotherapeutic?
Hepatitis B virus (HBV) is the most common cause of liver cancer in the world, resulting in approximately 880,000 deaths ...
JUN 01, 2021
Cancer
No level of secondhand smoke is safe for pregnant women
JUN 01, 2021
No level of secondhand smoke is safe for pregnant women
A study published recently in Environmental Health Perspectives concludes that no amount of exposure to secondhand smoke ...
JUN 16, 2021
Cell & Molecular Biology
A Potential Way to Prevent Metastatic Cancer
JUN 16, 2021
A Potential Way to Prevent Metastatic Cancer
Metastatic cancer is the deadliest, and it can happen years after cancer has been treated to the point of remission. Met ...
JUN 26, 2021
Cancer
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
JUN 26, 2021
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
Research shows that obese patients with cancers including ovarian and melanoma may respond better to a certain kind of i ...
AUG 01, 2021
Genetics & Genomics
Rethinking the Cause of Mutations That Lead to Melanoma
AUG 01, 2021
Rethinking the Cause of Mutations That Lead to Melanoma
Throughout our lives, new cells often replace the ones that become damaged or worn out. As cells divide, they have to re ...
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
Loading Comments...